Exozymes (EXOZ) Stock Price, News & Analysis

Company Overview

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquartered in Monrovia, California.

Key Stats

• Today's Range: $16.75 to $19.14
• 50-Day Range: N/A
• 52-Week Range: $8.50 to $23.99
• Volume: 8,151 shs
• Average Volume: 27,581 shs
• Market Capitalization: $105.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EXOZ Stock Analysis - Frequently Asked Questions

How have EXOZ shares performed this year?

Exozymes' stock was trading at $17.39 at the beginning of the year. Since then, EXOZ shares have decreased by 2.8% and is now trading at $16.91.
View the best growth stocks for 2025 here.

How do I buy shares of Exozymes?

Shares of EXOZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 3/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological products, except diagnostic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:EXOZ
• CIK: 2010788
• Web: N/A
• Phone: (626) 415-1488
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,252,000
• Free Float: N/A
• Market Cap: $105.72 million
• Optionable: N/A
• Beta: N/A